Tango drug combination shows 92% response rate in pancreatic cancer trial
Go back to Tango drug combination shows 92% response rate in pancreatic cancer trial| (NASDAQ: TNGX) | Delayed: 22.52 -0.24 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.76 | 52 Week High | $ | |||
| Open | $22.48 | 52 Week Low | $ | |||
| Day High | $22.94 | P/E | N/A | |||
| Day Low | $22.29 | EPS | $ | |||
| Volume | 1,457,381 | |||||

